Yaroslav Tsybovsky

Yaroslav Tsybovsky publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yaroslav Tsybovsky sits on this spectrum.

Yaroslav Tsybovsky D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yaroslav Tsybovsky sits on this spectrum.

Best Publications

• Rapid development of a DNA vaccine for Zika virus

  Kimberly A. Dowd;Sung-Youl Ko;Kaitlyn M. Morabito;Eun Sung Yang

  436
  Citations

• Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains.

  Tongqing Zhou;Yaroslav Tsybovsky;Jason Gorman;Micah Rapp

  371
  Citations

• Vaccine-Induced Antibodies that Neutralize Group 1 and Group 2 Influenza A Viruses

  M. Gordon Joyce;Adam K. Wheatley;Paul V. Thomas;Gwo-Yu Chuang

  349
  Citations

• Molecular-level analysis of the serum antibody repertoire in young adults before and after seasonal influenza vaccination

  Jiwon Lee;Daniel R. Boutz;Veronika Chromikova;M. Gordon Joyce

  313
  Citations

• Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses

  Masaru Kanekiyo;M Gordon Joyce;M Gordon Joyce;Rebecca A Gillespie;John R Gallagher

  310
  Citations

• Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

  K. Xu;P. Acharya;R. Kong;C. Cheng

  298
  Citations

• Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529

  Unknown

  280
  Citations

• A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques

  Unknown

  231
  Citations

• Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants.

  Jianliang Xu;Kai Xu;Kai Xu;Seolkyoung Jung;Andrea Conte

  219
  Citations

• Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer.

  Anna Kabanova;Jessica Marcandalli;Tongqing Zhou;Siro Bianchi

  203
  Citations

• Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens

  George Ueda;Aleksandar Antanasijevic;Jorge A Fallas;William Sheffler

  195
  Citations

• Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.

  Tongqing Zhou;Nicole A. Doria-Rose;Cheng Cheng;Guillaume B.E. Stewart-Jones

  187
  Citations

• Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants.

  Lingshu Wang;Tongqing Zhou;Yi Zhang;Eun Sung Yang

  186
  Citations

• Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells

  Wei Bu;M. Gordon Joyce;M. Gordon Joyce;Hanh Nguyen;Dalton V. Banh

  179
  Citations

• Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV.

  M Gordon Joyce;Baoshan Zhang;Li Ou;Man Chen

  176
  Citations

• Glycan Masking Focuses Immune Responses to the HIV-1 CD4-Binding Site and Enhances Elicitation of VRC01-Class Precursor Antibodies.

  Hongying Duan;Xuejun Chen;Jeffrey C. Boyington;Cheng Cheng

  141
  Citations

• Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages

  Kizzmekia S Corbett;Syed M Moin;Hadi M Yassine;Alberto Cagigi

  140
  Citations

• A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone.

  Baoshan Zhang;Cara W. Chao;Yaroslav Tsybovsky;Olubukola M. Abiona

  125
  Citations

• Preferential induction of cross-group influenza A hemagglutinin stem-specific memory B cells after H7N9 immunization in humans.

  Sarah F. Andrews;M. Gordon Joyce;Michael J. Chambers;Rebecca A. Gillespie

  118
  Citations

• Longitudinal Analysis Reveals Early Development of Three MPER-Directed Neutralizing Antibody Lineages from an HIV-1-Infected Individual.

  S.J. Krebs;Y.D. Kwon;C.A. Schramm;W.H. Law

  112
  Citations